The invention relates to extended release tablets of gliclazide and particularly deals with an improved formulation of gliclazide extended release tablets using hot melt granulation technology. Gliclazide extended release tablet formulation(Hot Melt) with polyethylene glycol 8000 along with hydroxypropylmethyl ...
3.Pharmacokinetics of darifenacin extended-release tablets in healthy Chinese volunteers达非那新缓释片在健康中国人体内的药动学 4.Pharmacokinetics and relative bioavailability of modified-release tablets of potassium chloride in healthy volunteers氯化钾缓释片健康人体的生物等效性 5.Evaluation of the effect on...
Extended Release Gliclazide Formulations extended release gliclazide formulationsan extended release gliclazide formulation which does not increase the blood glucose level in human C Umit; 被引量: 37发表: 2009年 Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different ...
Similarly, the Xrise study showed that a newer formulation, the breakable extended release gliclazide 60 mg, was effective in achieving HbA1c < 7% with low HEs (Mohan et al., 2015). The EASYDia study revealed that progressive up titration of the gliclazide was associated with a mean ...
In-vitro and in-vivo correlation for two gliclazide extended-release tablets The aim of this study was to perform an in-vitro-in-vivo correlation (IVIVC) for two 60-mg gliclazide extended-release formulations (Fast and Slow release)... U Mandal,KK Ray,V Gowda,... - 《Journal of Pharmacy...
This unique pattern of drug release of PLGA second generation smarter nanocrystals can be explored to meet the typical physiological needs of T2DM patients, such as a faster drug release at the time of meals followed by prolonged drug release profile over an extended period of time to maintain ...
and Kusum D.V., "Development of Extended Zero-Order Release Gliclazide Tablets by Central Composite Design, Drug Development and Industrial Pharmacy", 2008; p. 34:33-45.Vijayalakshmi P, Kusum Devi V, Narendra C, et al. Development of extended zero-order release Gliclazide tablets by central...
Formulation of gliclazide in the form of extendedrelease tablet in 30 and 60 mg dosage forms was performed using hypromellose (HPMC K4M) as a retarding agent. Drug-release profiles were investigated in comparison with references Diamicron MR 30 and 60 mg tablets. The effect of size of powder ...
Extended release gliclazide tabletThe present invention relates to prolonged release tablets. Tablets which are the subject of invention have not content excipients which have a high glisemic index and show uniformity release profile in pH 6.4 -7.2....
The invention relates to a matrix tablet for the prolonged release of gliclazide which ensures continuous and consistent release of the active ingredient after administration by the oral route, the release being insensitive to variations in the pH of the dissolution medium.HUET DE BAROCHEZ BRUNO...